Soft Tissue Infections
📧 Sign up to get email alerts when something new happens for Soft Tissue Infections.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Tenkasi (previously Orbactiv) (oritavancin (diphosphate)) — Menarini International Operations Luxembourg S.A.
EMA has authorised Tenkasi (oritavancin diphosphate) for soft tissue infections and bacterial skin diseases, expanding therapeutic options.
-
EMA approval · 2026-02-23EMA Authorised: Emblaveo (avibactam;aztreonam) — Pfizer Europe MA EEIG
The EMA authorised Emblaveo (avibactam/aztreonam) for treating certain Gram-negative bacterial infections, including urinary tract infection…
-
EMA approval · 2025-09-26EMA Authorised: Tigecycline Accord (tigecycline) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Tigecycline Accord (tigecycline) for use by Accord Healthcare S.L.U. for soft tissue infections, in…
-
EMA approval · 2025-03-20EMA Authorised: Sivextro (tedizolid) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Sivextro (tedizolid) by Merck Sharp & Dohme B.V. for the treatment of soft tissue infections and ba…